124 related articles for article (PubMed ID: 17910945)
1. Regulation of SOX3 gene expression is driven by multiple NF-Y binding elements.
Krstic A; Mojsin M; Stevanovic M
Arch Biochem Biophys; 2007 Nov; 467(2):163-73. PubMed ID: 17910945
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity.
Kovacevic Grujicic N; Mojsin M; Krstic A; Stevanovic M
Gene; 2005 Jan; 344():287-97. PubMed ID: 15656994
[TBL] [Abstract][Full Text] [Related]
3. PBX1 and MEIS1 up-regulate SOX3 gene expression by direct interaction with a consensus binding site within the basal promoter region.
Mojsin M; Stevanovic M
Biochem J; 2009 Dec; 425(1):107-16. PubMed ID: 19799567
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of the SOX3 gene expression by retinoic acid: characterization of the novel promoter-response element and the retinoid receptors involved.
Nikcević G; Savić T; Kovacević-Grujicić N; Stevanović M
J Neurochem; 2008 Dec; 107(5):1206-15. PubMed ID: 18786169
[TBL] [Abstract][Full Text] [Related]
5. Mapping of the RXRalpha binding elements involved in retinoic acid induced transcriptional activation of the human SOX3 gene.
Mojsin M; Grujicić NK; Nikcević G; Krstić A; Savić T; Stevanović M
Neurosci Res; 2006 Dec; 56(4):409-18. PubMed ID: 17005281
[TBL] [Abstract][Full Text] [Related]
6. Two distinct classes of CCAAT box elements that bind nuclear factor-Y/alpha-actinin-4: potential role in human CYP1A1 regulation.
Poch MT; Al-Kassim L; Smolinski SM; Hines RN
Toxicol Appl Pharmacol; 2004 Sep; 199(3):239-50. PubMed ID: 15364540
[TBL] [Abstract][Full Text] [Related]
7. Expression of the Op18 gene is maintained by the CCAAT-binding transcription factor NF-Y.
Benlhabib H; Herrera JE
Gene; 2006 Aug; 377():177-85. PubMed ID: 16757134
[TBL] [Abstract][Full Text] [Related]
8. Cell-specific regulation of TRBP1 promoter by NF-Y transcription factor in lymphocytes and astrocytes.
Bannwarth S; Lainé S; Daher A; Grandvaux N; Clerzius G; Leblanc AC; Hiscott J; Gatignol A
J Mol Biol; 2006 Feb; 355(5):898-910. PubMed ID: 16343534
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Clara cell secretory protein gene expression by the CCAAT-binding factor NF-Y.
Acosta A; Zariñán T; Macías H; Pasapera AM; Pérez-Solis MA; Olivares A; Ulloa-Aguirre A; Gutiérrez-Sagal R
Arch Biochem Biophys; 2007 Mar; 459(1):33-9. PubMed ID: 17188642
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional activation of the human HMG1 gene in cisplatin-resistant human cancer cells.
Nagatani G; Nomoto M; Takano H; Ise T; Kato K; Imamura T; Izumi H; Makishima K; Kohno K
Cancer Res; 2001 Feb; 61(4):1592-7. PubMed ID: 11245470
[TBL] [Abstract][Full Text] [Related]
11. p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y.
Faniello MC; Di Sanzo M; Quaresima B; Baudi F; Di Caro V; Cuda G; Morrone G; Del Sal G; Spinelli G; Venuta S; Costanzo F
Int J Biochem Cell Biol; 2008; 40(10):2110-9. PubMed ID: 18372207
[TBL] [Abstract][Full Text] [Related]
12. Dual transcriptional control of claudin-11 via an overlapping GATA/NF-Y motif: positive regulation through the interaction of GATA, NF-YA, and CREB and negative regulation through the interaction of Smad, HDAC1, and mSin3A.
Lui WY; Wong EW; Guan Y; Lee WM
J Cell Physiol; 2007 Jun; 211(3):638-48. PubMed ID: 17226765
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of the murine C5a receptor gene: NF-Y is required for basal and LPS induced expression in macrophages and endothelial cells.
Hunt JR; Martin CB; Martin BK
Mol Immunol; 2005 Jul; 42(11):1405-15. PubMed ID: 15950736
[TBL] [Abstract][Full Text] [Related]
14. The oncogenic potential of the high mobility group box protein Sox3.
Xia Y; Papalopulu N; Vogt PK; Li J
Cancer Res; 2000 Nov; 60(22):6303-6. PubMed ID: 11103788
[TBL] [Abstract][Full Text] [Related]
15. Lack of P-glycoprotein expression by low-dose fractionated radiation results from loss of nuclear factor-kappaB and NF-Y activation in oral carcinoma cells.
Shareef MM; Brown B; Shajahan S; Sathishkumar S; Arnold SM; Mohiuddin M; Ahmed MM; Spring PM
Mol Cancer Res; 2008 Jan; 6(1):89-98. PubMed ID: 18234965
[TBL] [Abstract][Full Text] [Related]
16. Comparison of promoter regions of SOX3, SOX14 and SOX18 orthologs in mammals.
Kovacevic-Grujicic N; Mojsin M; Djurovic J; Petrovic I; Stevanovic M
DNA Seq; 2008 Jun; 19(3):185-94. PubMed ID: 17852354
[TBL] [Abstract][Full Text] [Related]
17. YY1 and NF-Y binding sites regulate the transcriptional activity of the dek and dek-can promoter.
Sitwala KV; Adams K; Markovitz DM
Oncogene; 2002 Dec; 21(57):8862-70. PubMed ID: 12483538
[TBL] [Abstract][Full Text] [Related]
18. Transcription factor NF-Y regulates mdr1 expression through binding to inverted CCAAT sequence in drug-resistant human squamous carcinoma cells.
Okamura H; Yoshida K; Sasaki E; Morimoto H; Haneji T
Int J Oncol; 2004 Oct; 25(4):1031-7. PubMed ID: 15375553
[TBL] [Abstract][Full Text] [Related]
19. Positive regulation of promoter activity of human 3-phosphoglycerate dehydrogenase (PHGDH) gene is mediated by transcription factors Sp1 and NF-Y.
Jun DY; Park HS; Lee JY; Baek JY; Park HK; Fukui K; Kim YH
Gene; 2008 May; 414(1-2):106-14. PubMed ID: 18378410
[TBL] [Abstract][Full Text] [Related]
20. TG-interacting factor (TGIF) downregulates SOX3 gene expression in the NT2/D1 cell line.
Mojsin M; Popovic J; Kovacevic Grujicic N; Stevanovic M
J Genet Genomics; 2012 Jan; 39(1):19-27. PubMed ID: 22293114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
